Euroapi S.A. (OTCMKTS:EAPIF) Sees Significant Growth in Short Interest

Euroapi S.A. (OTCMKTS:EAPIF) was the target of a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 28,026 shares, an increase of 63.3% from the September 30th total of 17,158 shares. Based on an average trading volume of 549 shares, the days-to-cover ratio is currently 51.0 days.

Euroapi Price Performance

Euroapi stock remained flat at C$0.89 during trading hours on Monday. 14 shares of the company’s stock traded hands, compared to its average volume of 1,659. The business’s 50 day moving average is C$0.99 and its 200-day moving average is C$1.53. Euroapi has a 52-week low of C$0.84 and a 52-week high of C$3.46.

About Euroapi

EUROAPI is a France-based pharmaceutical company that develops, manufactures and markets active pharmaceutical ingredients (APIs), the substances responsible for the therapeutic effects of medicines. The company supplies APIs for use in a range of prescription and over-the-counter medicines, serving pharmaceutical companies and other healthcare customers.

Its portfolio includes chemical and biological APIs, as well as specialized products such as peptides and complex molecules. EUROAPI also provides contract development and manufacturing services, supporting customers from process development and scale-up through commercial production and regulatory supply.

EUROAPI was established in 2022 through the separation and listing of Sanofi’s API business.